Guidotti Jacopo

Roy Sylvain, Villamarin Adan, Stergiopulos Constantinos, Bigler Stéphane, Guidotti Jacopo, Stergiopulos Nikolaos et al.

This study found the adjustable eyeWatch device effectively controlled IOP and reduced medications in refractory glaucoma, allowing non-invasive post-operative adjustments to prevent hypotony and reinterventions.

Mansouri Kaweh, Gillmann Kevin, Rao Harsha L, Guidotti Jacopo, Mermoud André

This study found the XEN gel implant similarly effective and safe for reducing eye pressure in both pseudoexfoliative and primary open-angle glaucoma, making it a viable treatment option for both conditions.

Mansouri Kaweh, Guidotti Jacopo, Rao Harsha L, Ouabas Adel, D'Alessandro Elisa, Roy Sylvain et al.

This study found XEN gel implants, alone or with cataract surgery, safely and effectively lowered eye pressure and medication use in glaucoma patients for one year, offering a good treatment option.

Salinas Lauriane, Chaudhary Ankita, Guidotti Jacopo, Mermoud André, Mansouri Kaweh

A leaking bleb after XEN Gel Stent surgery was successfully managed by bleb revision, conjunctival suturing, and XEN replacement, demonstrating a repair strategy for this complication.